Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Borgono, J. M.
Right arrow Articles by Hilleman, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borgono, J. M.
Right arrow Articles by Hilleman, M. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Field Trial of Combined Measles- Mumps-Rubella Vaccine

Satisfactory Immunization with 188 Children in Chile

J. Manuel Borgono

Servido Nacional de Salud, Santiago, Chile

Rosa Greiber

Servido Nacional de Salud, Santiago, Chile

Giovanna Solari

Servido Nacional de Salud, Santiago, Chile

Fresia Concha

Servido Nacional de Salud, Santiago, Chile

Blanca Carrillo

Servido Nacional de Salud, Santiago, Chile

Maurice R. Hilleman

Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa. 19486

This report presents confirming evidence for the immunizing value of a trivalent combined measles-mumps-rubella vaccine (M-M-R), based on studies with 188 children in Chile. All of the children de veloped antibody against measles virus and 96 per cent developed antibodies against mumps and rubella. No clinical reaction occurred other than that expected to follow measles vaccine given alone.

Clinical Pediatrics, Vol. 12, No. 3, 170-172 (1973)
DOI: 10.1177/000992287301200311


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?